Homocysteine is an amino acid your body produces as a byproduct of processing methionine, an essential amino acid found in meat, fish, dairy, and other protein-rich foods. It has drawn decades of medical attention because elevated blood levels are linked to a surprisingly wide range of health problems, from heart disease and stroke to bone fractures, pregnancy complications, and cognitive decline. What makes homocysteine unusual is that while the associations are strong and well replicated, attempts to lower it with supplements have not always translated into the health benefits researchers expected. That disconnect has shaped one of the more interesting ongoing debates in nutrition and cardiovascular medicine.
How Your Body Processes Homocysteine
Homocysteine sits at a metabolic crossroads. When you eat protein, your body breaks it down into amino acids, including methionine. Methionine gets used for a critical process called methylation, which helps regulate gene expression, build proteins, and perform dozens of other chemical tasks. After methionine donates its methyl group, homocysteine is what remains. The body then has two options: recycle the homocysteine back into methionine, or break it down permanently into cysteine and eventually sulfate.
The recycling route happens in every tissue in your body and depends heavily on folate (vitamin B9) and vitamin B12 as helpers. The breakdown route, called transsulfuration, requires vitamin B6 and only operates in a handful of organs, primarily the liver and kidneys, with some activity in the small intestine and pancreas.1PubMed. Pathways and regulation of homocysteine metabolism in mammals Your body constantly balances how much homocysteine flows through each pathway, and when either route is impaired, homocysteine accumulates in the blood.2PubMed. The metabolism of homocysteine: pathways and regulation
What Counts as a Normal Level
Homocysteine is measured through a simple blood test, usually ordered as “total homocysteine” or “plasma tHcy.” Fasting levels between 5 and 15 micromoles per liter are generally considered normal.3Clinical Chemistry. Total homocysteine in plasma or serum: methods and clinical applications Levels above 15 are typically flagged as elevated, and very high readings above 50 or 100 can point toward a genetic metabolic disorder. The test is used for cardiovascular risk assessment, investigating unexplained blood clots, evaluating B vitamin deficiencies, and diagnosing rare inherited conditions like homocystinuria.4PubMed. Assessment of homocysteine status
A few practical quirks are worth knowing. Homocysteine levels tend to be higher in men than in women, rise with age, and can be affected by how long a blood sample sits before processing. Coffee consumption, smoking, and even physical inactivity can push levels up modestly. If your doctor orders the test, they will typically ask you to fast overnight for the most reliable reading.
What Pushes Homocysteine Up
The most common cause of mildly elevated homocysteine is simply not getting enough B vitamins, especially folate. Since folate is essential for recycling homocysteine back to methionine, low intake means the recycling slows and homocysteine builds up. Vitamin B12 plays a supporting role in the same pathway, and B6 is needed for the breakdown route. A meta-analysis of supplementation trials found that folic acid alone reduced homocysteine by about 25%, with B12 adding another 7% reduction on top of that.5PubMed. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements Interestingly, B6 supplements on their own did not lower homocysteine significantly, probably because B6 only matters for the transsulfuration pathway, which is not the dominant route in most tissues.
Beyond diet, genetics plays a real role. A common variant in the MTHFR gene, called C677T, reduces the efficiency of the enzyme that activates folate for homocysteine recycling. People who carry two copies of the T variant (one from each parent) tend to have higher homocysteine, especially when their folate intake is low.6PubMed. Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population This variant is surprisingly common in many populations, though its effect on health is heavily modulated by diet. Someone with two T copies who eats plenty of leafy greens may have perfectly normal homocysteine, while the same genotype combined with a folate-poor diet creates a noticeable bump.
Kidney disease is another major driver. The kidneys play a direct role in clearing homocysteine from the blood, so when kidney function declines, homocysteine levels rise. In patients with chronic kidney failure, the clearance of homocysteine from plasma drops to roughly 30% of normal, and the compound lingers in the blood about four times longer than it does in healthy people.7PubMed. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure This makes elevated homocysteine nearly universal in people on dialysis and is thought to partly explain the high cardiovascular risk in that population.8Nephrology Dialysis Transplantation. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
Several widely used medications also raise homocysteine. Metformin, the most commonly prescribed drug for type 2 diabetes, interferes with B12 absorption in the gut and can push levels up over time. Fibrate cholesterol drugs, certain anticonvulsants, methotrexate (used for rheumatoid arthritis and some cancers), and niacin have all been shown to increase homocysteine through various mechanisms.9PubMed. Drugs affecting homocysteine metabolism: impact on cardiovascular risk The clinical significance of these drug-induced increases remains debated, but it is worth flagging for people who take these medications long-term and are already at cardiovascular risk.10PubMed. Effect of drugs on homocysteine concentrations
How Homocysteine Damages Blood Vessels
The leading theory for why elevated homocysteine matters centers on the endothelium, the thin layer of cells lining every blood vessel. Homocysteine appears to injure these cells through several overlapping routes: it ramps up oxidative stress, reduces the availability of nitric oxide (the molecule that keeps blood vessels relaxed and flexible), promotes inflammation, and encourages the proliferation of smooth muscle cells in vessel walls.11PubMed Central. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide Lab research on heart microvascular cells has shown that homocysteine activates specific receptors that trigger reactive oxygen species production while simultaneously suppressing the body’s antioxidant defenses.12PubMed. Mechanisms of homocysteine-induced oxidative stress
Clinically, this damage shows up as impaired flow-mediated vasodilation, which is a measurable reduction in a blood vessel’s ability to widen when it needs to increase blood flow. Over time, this endothelial dysfunction is believed to set the stage for atherosclerosis, the buildup of plaque inside arteries.13PubMed Central. Role of homocysteine in the development of cardiovascular disease
Heart Disease, Stroke, and Blood Clots
Observational data consistently link higher homocysteine to cardiovascular events. A dose-response meta-analysis of prospective studies found that for every 1-micromole-per-liter increase in homocysteine, the risk of stroke rose by about 6%. People in the highest category of homocysteine had roughly 58% greater stroke risk compared with those in the lowest category.14Nutrition, Metabolism and Cardiovascular Diseases. Association of homocysteine level with risk of stroke: A dose–response meta-analysis of prospective cohort studies A separate meta-analysis focused specifically on ischemic stroke patients found their homocysteine levels were significantly higher than controls, with a pooled difference of nearly 4 micromoles per liter.15PubMed Central. The role of homocysteine levels as a risk factor of ischemic stroke events: a systematic review and meta-analysis
The relationship extends to blood clots. A study of patients with deep-vein thrombosis found that those with homocysteine levels above the 95th percentile had about 2.5 times the odds of a clot compared with controls, and the association persisted after accounting for other clotting risk factors like protein C deficiency or oral contraceptive use.16PubMed. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis The proposed mechanisms include increased tissue factor expression, enhanced platelet reactivity, and impaired fibrinolysis (the process that dissolves clots). That said, researchers generally consider elevated homocysteine a relatively weak prothrombotic factor compared with classic clotting disorders.17PubMed. Homocysteine and thrombosis: from basic science to clinical evidence
The B-Vitamin Paradox
Here is where the story gets genuinely puzzling. If high homocysteine damages blood vessels, and B vitamins reliably lower homocysteine, then B vitamin supplements should reduce heart attacks and strokes. Multiple large randomized trials tested exactly this hypothesis, and the results were consistently disappointing.
A major pooled analysis of trials involving over 37,000 people found that folic acid and B vitamin treatment reduced homocysteine by about 25% and maintained that reduction for an average of five years. Despite this, there was no meaningful effect on major vascular events, heart attacks, or stroke. The event rates were essentially identical in the supplement and placebo groups.18Archives of Internal Medicine. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality Separate reviews reached the same conclusion: the data do not support using B vitamins for cardiovascular protection in either middle-aged or older adults.19PubMed. Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults
This paradox has multiple possible explanations. One is that homocysteine is not itself the cause of vascular damage but rather a marker of something else, like poor B vitamin status or kidney dysfunction, that does the real harm. Another is that by the time patients in these trials enrolled (most already had established cardiovascular disease), the arterial damage was too advanced for lowering homocysteine to reverse. A third possibility is that the relationship is causal but that the degree of lowering achieved was too small or too late to matter. The debate remains unresolved, and it has made clinicians cautious about recommending B vitamins specifically for heart protection.
Brain Health and Cognitive Decline
The picture looks more promising when it comes to the brain. Elevated homocysteine has been identified as an independent predictor of cognitive decline and dementia risk.20PubMed. Impact of supplementation with vitamins B6, B12, and/or folic acid on the reduction of homocysteine levels in patients with mild cognitive impairment: A systematic review An international consensus statement concluded that B-vitamin treatment markedly slows both brain atrophy and cognitive decline in elderly people who already have cognitive impairment.21PubMed Central. Homocysteine and Dementia: An International Consensus Statement
One well-known randomized trial found that two years of high-dose B vitamins (B6, B12, and folic acid) slowed the rate of brain shrinkage by about 30% overall compared with placebo. The effect was even more dramatic in people who started with homocysteine above 13 micromoles per liter: their rate of brain atrophy was 53% lower in the treatment group. The same study showed that the rate of brain atrophy was a major determinant of how fast cognitive function declined.22PLOS ONE. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial A separate study in patients with Alzheimer’s disease and cerebrovascular disease found that a medical food targeting homocysteine slowed hippocampal and cortical atrophy, with the degree of slowing proportional to how much homocysteine was lowered.23PubMed. CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer’s Disease and Cerebrovascular Disease
Why might B vitamins help the brain but not the heart? One plausible explanation is that brain atrophy is a more direct and dose-responsive consequence of elevated homocysteine than arterial plaque buildup. Another is that the brain trials enrolled people earlier in their disease trajectory, catching the damage at a more reversible stage. Whatever the reason, the neurology findings are the strongest current argument for paying attention to homocysteine levels, particularly in older adults showing early signs of memory problems.
Pregnancy Complications
Homocysteine metabolism shifts during pregnancy: levels normally drop in the first and second trimesters, partly because of hemodilution and partly because the growing fetus demands large amounts of folate. When levels fail to drop, or when they are frankly elevated, problems can follow. High maternal homocysteine has been linked to pre-eclampsia, placental abruption, fetal growth restriction, recurrent miscarriage, and neural tube defects.24PubMed. Homocysteine and pregnancy The common thread in most of these complications appears to be damage to the blood vessels of the placenta, which restricts nutrient and oxygen delivery to the fetus.25PubMed Central. High Homocysteine Levels During Pregnancy and Its Association With Placenta-Mediated Complications: A Scoping Review
This is one area where the B-vitamin story aligns neatly. Folic acid supplementation before and during early pregnancy is one of the most successful public health interventions of the past half-century for preventing neural tube defects, and its effect on lowering homocysteine is likely part of the mechanism. Prenatal vitamins containing folate are already standard of care, which incidentally addresses the most common cause of elevated homocysteine in pregnant women.
Bone Fractures
A less widely known connection is between homocysteine and skeletal health. A large prospective study from the Netherlands found that people with homocysteine in the highest age-specific quartile had roughly double the fracture risk compared with those in the lowest quartile. Critically, this association held even after adjusting for bone mineral density, meaning the increased fracture risk was not simply because of thinner bones.26PubMed. Homocysteine levels and the risk of osteoporotic fracture
The mechanism appears to involve collagen. Homocysteine disrupts the cross-linking of collagen molecules in bone, increases oxidative stress in bone cells, and promotes the formation of advanced glycation end products that weaken the bone matrix. The result is bone that may look normal on a density scan but is structurally compromised and more likely to break under stress.27PubMed. The Effects of Homocysteine on the Skeleton This distinction between bone density and bone quality is important. Standard osteoporosis screening relies on density measurements, so someone with normal density but high homocysteine might still be at elevated fracture risk without it showing up on a routine scan.
Homocystinuria, the Rare Genetic Extreme
Classical homocystinuria is what happens when homocysteine metabolism is broken at a fundamental level. The most common form results from a deficiency in the enzyme cystathionine beta-synthase, which is responsible for the first step in homocysteine’s breakdown pathway. Without this enzyme functioning properly, homocysteine accumulates to levels far above the mild elevations seen in typical patients, often exceeding 100 micromoles per liter.28PubMed Central. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency
Severely affected children typically present with dislocated eye lenses, skeletal abnormalities, learning difficulties, and a high risk of blood clots. Some patients have a milder form that responds to high-dose pyridoxine (vitamin B6), while others require a strict low-methionine diet and betaine supplements to keep homocysteine levels under control. The dietary restrictions are effective but burdensome, and poor adherence is a persistent problem.29PubMed Central. Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria This rare condition is worth knowing about because it provided some of the earliest clinical evidence that very high homocysteine causes vascular damage, which later motivated the much larger body of research into mild elevations in the general population.
MTHFR Variants, Hypertension, and Stroke Risk
The MTHFR C677T variant has attracted enormous public attention, sometimes verging on health-influencer hype. The practical reality is more nuanced. Studies confirm that carrying the T allele raises homocysteine modestly, and that this effect is amplified in people with hypertension. In one large study, hypertensive T-allele carriers had average homocysteine levels of about 13.3 micromoles per liter compared with 12.8 in hypertensive C-allele carriers, a statistically significant but clinically small gap.30PubMed Central. Homocysteine levels, H-Hypertension, and the MTHFR C677T genotypes: A complex interaction
The interaction between MTHFR status, homocysteine, and stroke risk gets more complex. A trial examining folic acid intervention found that baseline homocysteine predicted first stroke in people with the CC or CT genotype, but the same relationship did not hold for those with the TT genotype.31PubMed. Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention This is a reminder that genes, nutrients, and disease risk interact in ways that do not always line up with simple expectations. Getting tested for MTHFR variants is easy and inexpensive, but the result mostly tells you to do what is already good advice for everyone: eat enough folate-rich foods and make sure you are not B12-deficient.
Connections to Mental Health
Research has found associations between elevated homocysteine and psychiatric conditions, including depression and schizophrenia. In one study of a South Indian population, both conditions were associated with higher plasma homocysteine levels, and the elevation correlated with the duration and severity of psychotic symptoms.32PubMed Central. Plasma homocysteine levels in depression and schizophrenia in South Indian Tamilian population The proposed mechanism ties back to methylation: homocysteine accumulation reflects impaired methylation capacity, and methylation reactions are critical for producing neurotransmitters like serotonin, dopamine, and norepinephrine. Whether correcting homocysteine levels improves psychiatric outcomes is a separate and much less settled question, but the biological plausibility is there. Clinicians working with patients who have treatment-resistant depression sometimes check homocysteine as part of a broader metabolic workup, particularly if B12 or folate deficiency is suspected.
Methylation and Epigenetic Effects
Beyond its well-known roles in vascular and neurological health, homocysteine has deeper biochemical consequences that researchers are still mapping. When homocysteine accumulates, so does its precursor S-adenosylhomocysteine, which is a potent inhibitor of methylation reactions throughout the body. Lab studies on vascular smooth muscle cells have shown that clinically relevant levels of homocysteine shifted the balance of key methylation compounds and led to widespread loss of DNA methylation, essentially altering how genes are turned on and off.33PubMed Central / Mary Ann Liebert, Inc.. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs This epigenetic dimension could help explain why homocysteine’s effects are so broad, touching everything from blood vessels to bone to brain tissue. If elevated homocysteine disrupts methylation at a genome-wide level, the downstream consequences would naturally span many organ systems rather than targeting just one.